MESO-Rx
Anabolic Steroids
Can touching a barbell in the gym get you sick with the coronavirus?
- Thread starter Michael Scally MD
- Start date
Villain
Member
As far as I know, Thailand didn’t take drastic measures. There were no severe lockdowns there and I was there with my buddy and his family when this all went down in February 2020. Chinese weren’t allowed in but masks were optional. My buddy’s family is from there and his aunts and uncles all worked as well as traveled for vacation within the country.
Villain
Member
500,000 is bullshit and then to say the totals are lagging is even more bullshit. With the deceit of labeling almost all deaths as Covid, of course they can say the death toll is 500,000. The truth already came out about the fudged numbers, so why should anyone take this 500,000 number seriously?
View: https://twitter.com/tribelaw/status/1364940559983521792?s=20
The short film above allows you to experience the brutality of the pandemic from the perspective of nurses inside a Covid-19 intensive care unit.
Opinion Video producer Alexander Stockton spent several days reporting at the Valleywise Medical Center in Phoenix. Two I.C.U. nurses wore cameras to show what it’s like to care for the sickest Covid patients a year into the pandemic.
So many Americans have died in hospitals without family by their side, but they were not alone. Nurses brush patients’ teeth, change their catheters and hold their hands in their final moments.
In just a year, we’ve lost half a million Americans to Covid-19. Vaccinations may be offering some relief, but inside I.C.U.s, nurses continue to contend with the trauma and grief of America’s carousel of death.
Villain
Member
Do people actually buy into this bullshit??? Oh wait, of course they do because they post here
nbc25news.com
Amid COVID-19 pandemic, flu has disappeared in the US
NEW YORK (AP) — February is usually the peak of flu season, with doctors' offices and hospitals packed with suffering patients. But not this year. Flu has virtually disappeared from the U. S. , with reports coming in at far lower levels than anything seen in decades. Experts say that measures...
nbc25news.com
View: https://twitter.com/CNN/status/1365016239391862790?s=20
(CNN) Wearing masks and other safety precautions are key to stop the spread of Covid-19 during indoor group exercise, according to two new reports published by the US Centers for Disease and Prevention.
The two studies, published Wednesday, linked Covid-19 outbreaks over the summer to exercise facilities in Chicago and Honolulu.
In the Chicago report, 60% of people who attended in-person fitness classes at one facility between August 24 and September 1 tested positive for Covid-19. Another 7% of attendees reported symptoms consistent with the disease.
While some mitigation measures were in place at the facility -- including required temperature checks and symptom screenings upon entry -- removal of masks was permitted during exercise, according to the report.
[OA] Severely Low Testosterone in Males With COVID-19
Background: Circulating androgens could have a relevant pathobiological role in clinical outcomes in men with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19).
Objectives: We aimed to assess:
i) circulating sex steroids levels in a cohort of 286 symptomatic men with laboratory-confirmed COVID-19 at hospital admission compared to a cohort of 281 healthy men;
ii) the association between serum testosterone levels (tT), COVID-19 and clinical outcomes.
Materials and methods: Demographic, clinical and hormonal values were collected for all patients. Hypogonadism was defined as tT ≤9.2 nmol/l. The Charlson Comorbidity Index (CCI) was used to score health-significant comorbidities. Severe clinical outcomes were defined as patients either transferred to intensive care unit (ICU) or death. Descriptive statistics and multivariable linear and logistic regression models tested the association between clinical and laboratory variables and tT levels. Univariable and multivariable logistic regression models tested the association between tT and severe clinical outcomes.
Results: Overall, a significantly lower levels of LH and tT were found in patients with COVID-19 compared to healthy controls (all P<0.0001); conversely, healthy controls depicted lower values of circulating E2 (P<0.001). Testosterone levels suggestive for hypogonadism were observed in 257 (89.8%) patients at hospital admission. In as many as 243 (85%) cases, hypogonadism was secondary.
SARS-CoV-2 infection status was independently associated with lower tT levels (P<0.0001) and greater risk of hypogonadism (P<0.0001), after accounting for age, BMI, CCI and IL-6 values. Lower tT levels were associated with higher risk of ICU admission and death outcomes (all P≤0.05), after accounting for clinical and laboratory parameters.
Conclusions: We unveil an independent association between SARS-CoV-2 infection status and secondary hypogonadism already at hospital admission, with lower testosterone levels predicting the most severe clinical outcomes.
Salonia A, Pontillo M, Capogrosso P, et al. Severely low testosterone in males with COVID-19: a case-control study. Andrology. 2021 Feb 26. doi: 10.1111/andr.12993. Epub ahead of print. PMID: 33635589. https://onlinelibrary.wiley.com/doi/10.1111/andr.12993
Background: Circulating androgens could have a relevant pathobiological role in clinical outcomes in men with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19).
Objectives: We aimed to assess:
i) circulating sex steroids levels in a cohort of 286 symptomatic men with laboratory-confirmed COVID-19 at hospital admission compared to a cohort of 281 healthy men;
ii) the association between serum testosterone levels (tT), COVID-19 and clinical outcomes.
Materials and methods: Demographic, clinical and hormonal values were collected for all patients. Hypogonadism was defined as tT ≤9.2 nmol/l. The Charlson Comorbidity Index (CCI) was used to score health-significant comorbidities. Severe clinical outcomes were defined as patients either transferred to intensive care unit (ICU) or death. Descriptive statistics and multivariable linear and logistic regression models tested the association between clinical and laboratory variables and tT levels. Univariable and multivariable logistic regression models tested the association between tT and severe clinical outcomes.
Results: Overall, a significantly lower levels of LH and tT were found in patients with COVID-19 compared to healthy controls (all P<0.0001); conversely, healthy controls depicted lower values of circulating E2 (P<0.001). Testosterone levels suggestive for hypogonadism were observed in 257 (89.8%) patients at hospital admission. In as many as 243 (85%) cases, hypogonadism was secondary.
SARS-CoV-2 infection status was independently associated with lower tT levels (P<0.0001) and greater risk of hypogonadism (P<0.0001), after accounting for age, BMI, CCI and IL-6 values. Lower tT levels were associated with higher risk of ICU admission and death outcomes (all P≤0.05), after accounting for clinical and laboratory parameters.
Conclusions: We unveil an independent association between SARS-CoV-2 infection status and secondary hypogonadism already at hospital admission, with lower testosterone levels predicting the most severe clinical outcomes.
Salonia A, Pontillo M, Capogrosso P, et al. Severely low testosterone in males with COVID-19: a case-control study. Andrology. 2021 Feb 26. doi: 10.1111/andr.12993. Epub ahead of print. PMID: 33635589. https://onlinelibrary.wiley.com/doi/10.1111/andr.12993
[OA] Potential Risk for Developing Severe COVID-19 Disease Among Anabolic Steroid Users
A severe case of COVID-19 was observed in an otherwise healthy 28-year-old man who had taken oxandrolone 40 mg/day as an anabolic steroid.
The patient had been taking oxandrolone for enhanced bodybuilding 30 days prior to presenting to an outpatient clinic with COVID-19 symptoms. The patient reported that his symptoms have rapidly worsened over the course of 4 days prior to presenting at the clinic.
As part of an experimental antiandrogen treatment for hyperandrogenic men suffering from COVID-19, he was administered a single 600 mg dose of the novel antiandrogen proxalutamide. Twenty-four hours after administration of this dose, marked improvement of symptoms and markers of disease severity were observed.
To our knowledge, this is the first case that potentially links anabolic steroid use to COVID-19 disease severity.
Cadegiani F, Lin EM, Goren A, Wambier CG. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26;14(2):e241572. doi: 10.1136/bcr-2021-241572. PMID: 33637513. Potential risk for developing severe COVID-19 disease among anabolic steroid users | BMJ Case Reports
A severe case of COVID-19 was observed in an otherwise healthy 28-year-old man who had taken oxandrolone 40 mg/day as an anabolic steroid.
The patient had been taking oxandrolone for enhanced bodybuilding 30 days prior to presenting to an outpatient clinic with COVID-19 symptoms. The patient reported that his symptoms have rapidly worsened over the course of 4 days prior to presenting at the clinic.
As part of an experimental antiandrogen treatment for hyperandrogenic men suffering from COVID-19, he was administered a single 600 mg dose of the novel antiandrogen proxalutamide. Twenty-four hours after administration of this dose, marked improvement of symptoms and markers of disease severity were observed.
To our knowledge, this is the first case that potentially links anabolic steroid use to COVID-19 disease severity.
Cadegiani F, Lin EM, Goren A, Wambier CG. Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ Case Rep. 2021 Feb 26;14(2):e241572. doi: 10.1136/bcr-2021-241572. PMID: 33637513. Potential risk for developing severe COVID-19 disease among anabolic steroid users | BMJ Case Reports
Similar threads
